| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 2 662-666, Copyright © 1990 by American Association of Immunologists
ARTICLES |
MN Marra, CG Wilde, JE Griffith, JL Snable and RW Scott
Invitron Corporation, Redwood City, CA 94063.
Neutrophil granules contain proteins important in host defense against bacterial pathogens. Granule proteins released from activated neutrophils facilitate opsonization, phagocytosis, tissue digestion, and antimicrobial activity. Three similar, if not identical, neutrophil proteins, bactericidal/permeability-increasing protein (BPI), 57,000 m.w. cationic antimicrobial protein, and bactericidal protein have been described that specifically kill gram negative bacteria. Since LPS is a structure common to all gram-negative bacteria, we investigated whether the microbicidal protein BPI affects biologic activity of LPS in vitro. Human neutrophils can be activated both in vitro and in vivo by LPS. Upon stimulation, surface expression of CR1 and CR3 increases markedly. Using flow microfluorimetry, we analyzed surface expression of CR1 and CR3 as a measure of neutrophil stimulation in response to LPS. CR up- regulation on neutrophils was TNF independent, suggesting direct LPS stimulation of neutrophils in this system. Purified BPI completely inhibited CR up-regulation on neutrophils stimulated with both rough and smooth LPS chemotypes at 1.8 to 3.6 nM (100 to 200 ng/ml). By comparison, the polypeptide antibiotic polymyxin B completely inhibited the same dose of LPS at 0.4 nM. The inhibitory activity of BPI appeared to be specific for LPS because neutrophil stimulation by formylated peptide or TNF was unaffected. The specificity of BPI for LPS was further demonstrated by inhibition of LPS activity in the limulus amebocyte lysate assay. Therefore, the role of BPI in infection may not be limited to its microbicidal activity, but it may also regulate the neutrophil response to LPS.
This article has been cited by other articles:
|
|
 |
|
  J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Schultz, J. Hume, D. S. Zhang, T. L. Gioannini, and J. P. Weiss A Novel Role for the Bactericidal/Permeability Increasing Protein in Interactions of Gram-Negative Bacterial Outer Membrane Blebs with Dendritic Cells J. Immunol., August 15, 2007; 179(4): 2477 - 2484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Srivastava, H. Casey, N. Johnson, O. Levy, and R. Malley Recombinant Bactericidal/Permeability-Increasing Protein rBPI21 Protects against Pneumococcal Disease Infect. Immun., January 1, 2007; 75(1): 342 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Canny, E. Cario, A. Lennartsson, U. Gullberg, C. Brennan, O. Levy, and S. P. Colgan Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G557 - G567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M.E. Bowdish and R. E.W. Hancock Anti-endotoxin properties of cationic host defence peptides and proteins Innate Immunity, August 1, 2005; 11(4): 230 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Augusto, M. Synguelakis, Q. Espinassous, M. Lepoivre, J. Johansson, and R. Chaby Cellular Antiendotoxin Activities of Lung Surfactant Protein C in Lipid Vesicles Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Reichel, C. Seemann, E. Csernok, J.-M. Schroder, A. Muller, W. L. Gross, and H. Schultz Bactericidal/Permeability-Increasing Protein Is Expressed by Human Dermal Fibroblasts and Upregulated by Interleukin 4 Clin. Vaccine Immunol., May 1, 2003; 10(3): 473 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Majerle, J. Kidric, and R. Jerala Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain J. Antimicrob. Chemother., May 1, 2003; 51(5): 1159 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Thomas, M. F. Tsen, D. J. White, and J. W. Horton TLR4 inactivation and rBPI21 block burn-induced myocardial contractile dysfunction Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1645 - H1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inagawa, T. Honda, C. Kohchi, T. Nishizawa, Y. Yoshiura, T. Nakanishi, Y. Yokomizo, and G.-I. Soma Cloning and Characterization of the Homolog of Mammalian Lipopolysaccharide-Binding Protein and Bactericidal Permeability-Increasing Protein in Rainbow Trout Oncorhynchus mykiss J. Immunol., June 1, 2002; 168(11): 5638 - 5644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ganz Epithelia: Not just physical barriers PNAS, March 19, 2002; 99(6): 3357 - 3358. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schafer, A. Parlesak, C. Schutt, J. Christian Bode, and C. Bode CONCENTRATIONS OF LIPOPOLYSACCHARIDE-BINDING PROTEIN, BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN, SOLUBLE CD14 AND PLASMA LIPIDS IN RELATION TO ENDOTOXAEMIA IN PATIENTS WITH ALCOHOLIC LIVER DISEASE Alcohol Alcohol., January 1, 2002; 37(1): 81 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schultz, J. Weiss, S. F. Carroll, and W. L. Gross The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies J. Leukoc. Biol., April 1, 2001; 69(4): 505 - 512. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Levy A Neutrophil-Derived Anti-Infective Molecule: Bactericidal/Permeability-Increasing Protein Antimicrob. Agents Chemother., November 1, 2000; 44(11): 2925 - 2931. [Full Text]
|
|
|
|
|
|
E. Bülow, U. Gullberg, and I. Olsson Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein J. Leukoc. Biol., November 1, 2000; 68(5): 669 - 678. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Locht, T. Skogh, and A. Wiik Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis Ann Rheum Dis, November 1, 2000; 59(11): 898 - 903. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Levy Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents Blood, October 15, 2000; 96(8): 2664 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. David, S. K. Awasthi, and P. Balaram The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides Innate Immunity, June 1, 2000; 6(3): 249 - 256. [Abstract] [PDF]
|
|
|
|
 |
|
 N. S. TAN, B. HO, and J. L. DING High-affinity LPS binding domain(s) in recombinant factor C of a horseshoe crab neutralizes LPS-induced lethality FASEB J, May 1, 2000; 14(7): 859 - 870. [Abstract] [Full Text]
|
|
|
|
|
|
S. Dankesreiter, A. Hoess, J. Schneider-Mergener, H. Wagner, and T. Miethke Synthetic Endotoxin-Binding Peptides Block Endotoxin- Triggered TNF-{alpha} Production by Macrophages In Vitro and In Vivo and Prevent Endotoxin-Mediated Toxic Shock J. Immunol., May 1, 2000; 164(9): 4804 - 4811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Soler-Rodriguez, H. Zhang, H. S. Lichenstein, N. Qureshi, D. W. Niesel, S. E. Crowe, J. W. Peterson, and G. R. Klimpel Neutrophil Activation by Bacterial Lipoprotein Versus Lipopolysaccharide: Differential Requirements for Serum and CD14 J. Immunol., March 1, 2000; 164(5): 2674 - 2683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. J. Dixon, R. S. Heyderman, K. Kotovicz, D. L. Jack, S. R. Andersen, U. Vogel, M. Frosch, and N. Klein Endothelial Adhesion Molecule Expression and Its Inhibition by Recombinant Bactericidal/Permeability-Increasing Protein Are Influenced by the Capsulation and Lipooligosaccharide Structure of Neisseria meningitidis Infect. Immun., November 1, 1999; 67(11): 5626 - 5633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Khan, L. H. Lambert Jr., J. S. Remington, and F. G. Araujo Recombinant Bactericidal/Permeability-Increasing Protein (rBPI21) in Combination with Sulfadiazine Is Active against Toxoplasma gondii Antimicrob. Agents Chemother., April 1, 1999; 43(4): 758 - 762. [Abstract] [Full Text]
|
|
|
|
|
|
M. Yoshida, Y. Wakatsuki, Y. Kobayashi, T. Itoh, K. Murakami, A. Mizoguchi, T. Usui, T. Chiba, and T. Kita Cloning and Characterization of a Novel Membrane-Associated Antigenic Protein of Helicobacter pylori Infect. Immun., January 1, 1999; 67(1): 286 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Drabick, A. K. Bhattacharjee, D. L. Hoover, G. E. Siber, V. E. Morales, L. D. Young, S. L. Brown, and A. S. Cross Covalent Polymyxin B Conjugate with Human Immunoglobulin G as an Antiendotoxin Reagent Antimicrob. Agents Chemother., March 1, 1998; 42(3): 583 - 588. [Abstract] [Full Text]
|
|
|
|
|
|
A.W.M. Pui, B. Ho, and J.L. Ding Yeast recombinant Factor C from horseshoe crab binds endotoxin and causes bacteriostasis Innate Immunity, December 1, 1997; 4(6): 391 - 400. [Abstract] [PDF]
|
|
|
|
|
|
L.C.J.M. Lemaire, T. van der Poll, J.J.B. van Lanschot, H.M. Levels, B. van der Ende, S.J.H. van Deventer, and D.J. Gouma Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines Innate Immunity, October 1, 1997; 4(5): 331 - 338. [Abstract] [PDF]
|
|
|
|
 |
|
 S. L. Abrahamson, H.-M. Wu, R. E. Williams, K. Der, N. Ottah, R. Little, H. Gazzano-Santoro, G. Theofan, R. Bauer, S. Leigh, et al. Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/ Permeability-increasing Protein. IMPLICATIONS IN BIOLOGICAL ACTIVITY J. Biol. Chem., January 24, 1997; 272(4): 2149 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Falk, M.A. Fletcher, T.J. Williams, W.M. Ching, Y. Wu, and T.K. Morrison Aggregation of serum proteins with lipopolysaccharide (LPS): characterization of the precipitable LPS-protein complex Innate Immunity, April 1, 1996; 3(2): 129 - 142. [Abstract] [PDF]
|
|
|
|
 |
|
 R. J. Burnett, C. A. Lyden, C. J. Tindal, C. M. Cave, M. N. Marra, and J. S. Solomkin Mononuclear Cell Line THP-1 Internalizes Bactericidal/Permeability-Increasing Protein by a Non--Receptor-Mediated Mechanism Consistent With Pinocytosis Arch Surg, February 1, 1996; 131(2): 200 - 206. [Abstract] [PDF]
|
|
|
|
|
|
R.J. Burnett, C.A. Lyden, C.J. Tindal, M.N. Marra, A.N. Neely, and J.S. Solomkin Effects of bactericidal/permeability-increasing protein upon mononuclear cell interactions with endotoxin: evidence for cell binding Innate Immunity, October 1, 1995; 2(5): 349 - 357. [Abstract] [PDF]
|
|
|
|
|
|
A. H. Taylor, G. Heavner, M. Nedelman, D. Sherris, E. Brunt, D. Knight, and J. Ghrayeb Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein J. Biol. Chem., July 28, 1995; 270(30): 17934 - 17938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-c. Jiang and C. Bruce Regulation of Murine Plasma Phospholipid Transfer Protein Activity and mRNA Levels by Lipopolysaccharide and High Cholesterol Diet J. Biol. Chem., July 21, 1995; 270(29): 17133 - 17138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.A. David, P. Balaram, and V.I. Mathan Characterization of the interaction of lipid A and lipopolysaccharide with human serum albumin: implications for an endotoxin carrier function for albumin Innate Immunity, April 1, 1995; 2(2): 99 - 106. [Abstract] [PDF]
|
|
|
|
|
|
G. Famularo, C. De Simone, E. Arrigoni Martelli, and E. Jirillo Carnitine and septic shock: a review Innate Immunity, April 1, 1995; 2(2): 141 - 147. [Abstract] [PDF]
|
|
|
|
|
|
R. Porat, H.N. Paddock, F. Cominelli, M.N. Marra, R.W. Scott, S.D. Schwaitzberg, and C.A. Dinarello Effects of bactericidal/permeability-increasing protein on endotoxin-induced fever and Escherichia coli-induced shock in rabbits Innate Immunity, February 1, 1995; 2(1): 9 - 18. [Abstract] [PDF]
|
|
|
|
|
|
H.H.F. Derkx, K.F. Bruin, C.V. Jongeneel, L.P. de Waal, B.M.N. Brinkman, C.L. Verweij, J.J. Houwing-Duistermaat, F.R. Rosendaal, and S.J.H. van Deventer Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro; relationship to TNF gene polymorphism Innate Immunity, February 1, 1995; 2(1): 19 - 25. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Carlson, E. Lightfoot Jr., D. D. Bryant, S. B. Haudek, D. Maass, J. Horton, and B. P. Giroir Burn plasma mediates cardiac myocyte apoptosis via endotoxin Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1907 - H1914. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
